Locate Available Clinical Trials

To view available Clinical Trial information choose from the list on the right or search using the fields below.



trial #
trial description
  • Alliance A011104
  • The purpose of this study is to test whether patients undergoing a breast MRI (called magnetic resonance imaging) before breast cancer surgery will have better results after the surgery.

  • Alliance A211102
  • The purpose of this research study is to test whether metformin, a drug commonly used to treat diabetes, is able to get rid of atypia (or marker of breast cancer risk) in women at increased risk for breast cancer.  We will test for the presence of atypia in the breast after metformin is given to see if it can get rid of atypia. We would like to compare the effects, good and/or bad, of metformin or placebo on atypia to find out which is better.  In this study, you will get either metformin or a placebo (an inactive product) for the first twelve months.  After the first twelve months, women who received placebo during the first twelve months can choose to receive metformin for the second year.

  • Alliance A221101
  • The purpose of this study is to see if taking the study drug, armodafinil, at a dose of 150mg or 250mg, will improve problems with fatigue in patients who have been diagnosed with brain cancer and are experiencing fatigue. In this study, you will take either the study drug, armodafinil, or the placebo (inactive drug).  You will not take both. 

  • NRG/GOG 0225
  • The purpose of this study is to find out if a change in diet and exercise in women with primary peritoneal, fallopian tube and ovarian cancer has an effect on the length of time you are cancer free following your initial treatment.

  • NRG/GOG 0237
  • The main purpose of this study is to determine whether the presence of human Papillomavirus (called HPV) and certain chemical substances (called biomarkers) in cervical cells can help identify which women with a cytologic diagnosis of AGC have a benign condition and which have a pre-cancerous condition or an invasive cancer that requires surgical removal.  

  • SWOG S0820
  • The purpose of this study is to determine if eflornithine and sulindac, taken alone or in combination, can decrease the risk of high-risk adenomas or second primary colorectal cancers in patients who have been treated for Stage 0, I, II or III colon cancer. 

  • URCC 14040
  • Sleep disturbance, particularly insomnia, is a common problem for cancer survivors.  Insomnia can be described as excessive daytime napping, difficulty falling asleep, difficulty staying asleep, or waking up earlier than you would like.  Insomnia can increase fatigue, impair physical function, impair immune function, cause circadian rhythms (known as your biological clock) to be disrupted and decrease quality of life. Because there is no ideal standard of care for effectively treating sleep problems in cancer survivors, the purpose of this study is to compare the effectiveness of three different treatments for improving sleep problems and determine which is best.  The three treatments are yoga, survivorship health education, and cognitive behavioral therapy.  

  • WF 10217
  • The purpose of this study is to gather information that will help us better understand how being a cancer survivor affects work and related outcomes in young adults.